TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 1 filers reported holding TYRA BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,000 | -25.6% | 2,134 | -6.3% | 0.00% | – |
| Q2 2023 | $39,000 | +225.0% | 2,277 | +206.9% | 0.00% | – |
| Q1 2023 | $12,000 | -52.0% | 742 | -77.8% | 0.00% | – |
| Q4 2022 | $25,000 | +2400.0% | 3,344 | +1990.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 160 | +116.2% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 74 | -89.8% | 0.00% | – |
| Q1 2022 | $8,000 | -77.1% | 725 | -70.9% | 0.00% | – |
| Q4 2021 | $35,000 | – | 2,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |